# Sodium-Lactate and Traumatic Brain Injury

> **NCT00319345** · PHASE2,PHASE3 · TERMINATED · sponsor: **Institut d'Anesthesiologie des Alpes Maritimes** · enrollment: 34 (—)

## Conditions studied

- Severe Trauma Brain Injury
- Intracranial Hypertension

## Interventions

- **DRUG:** Mannitol, Sodium-Lactate

## Key facts

- **NCT ID:** NCT00319345
- **Lead sponsor:** Institut d'Anesthesiologie des Alpes Maritimes
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-11
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** 34 (—)
- **Last updated:** 2010-06-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00319345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00319345, "Sodium-Lactate and Traumatic Brain Injury". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00319345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*